ChemoCentryx Stock News

In a report released today, Michelle Gilson from Canaccord Genuity reiterated a Buy rating on Homology Medicines ( FIXX – Research Report ), with a price target of $37.00 . The company’s shares cl

Canaccord Genuity analyst Michelle Gilson maintained a Buy rating on Homology Medicines (FIXX) on April 3 and set a price target of $37.00. The company's

Canaccord Genuity analyst Michelle Gilson maintained a Buy rating on Homology Medicines (FIXX – Research Report) on April 3 and

ChemoCentryx Inc (NASDAQ:CCXI) – Stock analysts at SVB Leerink issued their Q1 2020 earnings per share estimates for ChemoCentryx in a research report issued on Wednesday, April 1st. SVB Leerink ana

SVB Leerink reissued their outperform rating on shares of ChemoCentryx (NASDAQ:CCXI) in a research note issued to investors on Wednesday morning, Zacks.com reports. Several other analysts have also we

Victory Capital Management Inc. raised its position in ChemoCentryx Inc (NASDAQ:CCXI) by 45.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & E

Brokerages expect ChemoCentryx Inc (NASDAQ:CCXI) to announce $8.90 million in sales for the current fiscal quarter, according to Zacks Investment Research. Five analysts have made estimates for ChemoC

Equities research analysts at SVB Leerink assumed coverage on shares of ChemoCentryx (NASDAQ:CCXI) in a note issued to investors on Thursday, TipRanks reports. The brokerage set a “buy” rating and

Credit Suisse AG grew its holdings in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 53.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 27,043 shares of the bi

Enphase Energy makes the list Continue reading...

5 Guru Stocks That Beat the Market, Stocks: AXSM,CCXI,DXCM,EIDX,ENPH, release date:Mar 31, 2020

Amalgamated Bank purchased a new stake in ChemoCentryx Inc (NASDAQ:CCXI) during the fourth quarter, HoldingsChannel reports. The firm purchased 7,339 shares of the biopharmaceutical company’s stock,

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

ChemoCentryx Inc (NASDAQ:CCXI) Director Geoffrey M. Parker sold 30,000 shares of the stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $36.70, for a total value o